These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22903480)

  • 1. A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors.
    Asadzadeh J; Asadi MH; Shakhssalim N; Rafiee MR; Kalhor HR; Tavallaei M; Mowla SJ
    Urol J; 2012; 9(3):574-80. PubMed ID: 22903480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
    Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
    Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of anti-apoptotic genes in tumor cell lines is facilitated by suppression of OCT4B1.
    Mirzaei MR; Mahmoodi M; Hassanshahi G; Ahmadi Z
    Adv Med Sci; 2017 Mar; 62(1):97-102. PubMed ID: 28235715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines.
    Mirzaei MR; Najafi A; Arababadi MK; Asadi MH; Mowla SJ
    Tumour Biol; 2014 Oct; 35(10):9999-10009. PubMed ID: 25008565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
    Asadi MH; Khalifeh K; Mowla SJ
    J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.
    Gazouli M; Roubelakis MG; Theodoropoulos GE; Papailiou J; Vaiopoulou A; Pappa KI; Nikiteas N; Anagnou NP
    Mol Carcinog; 2012 Feb; 51(2):165-73. PubMed ID: 21480394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response.
    Farashahi Yazd E; Rafiee MR; Soleimani M; Tavallaei M; Salmani MK; Mowla SJ
    Cancer Lett; 2011 Oct; 309(2):170-5. PubMed ID: 21684074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer.
    Nikpour M; Emadi-Baygi M; Fischer U; Niegisch G; Schulz WA; Nikpour P
    Urol Oncol; 2014 Jul; 32(5):670-7. PubMed ID: 24495449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
    Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
    Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
    Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
    Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
    Kim EJ; Lee YS; Kim YJ; Kim MJ; Ha YS; Jeong P; Lee OJ; Kim WJ
    Urology; 2010 Jun; 75(6):1516.e9-13. PubMed ID: 19913893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.